Clinical Research at MSU

Similar documents
Clinical & Translational Research, What is it and Why Should I Care?

Human Research Protection Program Guidance for Human Research Determination

ROLE OF THE RESEARCH COORDINATOR Study Startup Best Practices May 2016

MCW Office of Research Standard Operating Procedure

Clinical Trial Basics:

Clinical Trials Series Part II

4.2. Investigator Regulatory Binder: Files, usually a binder, maintained by the investigator at the investigative site.

ClinicalTrials.gov Updates. Gabrielle Gaspard Assistant Director Human Research Compliance

HCCA: Compliance in Conducting Clinical Research: Conflict of Interest

TOP 10 INVESTIGATOR RESPONSIBILITIES WHEN CONDUCTING HUMAN SUBJECTS RESEARCH

POLICY AND PROCEDURE MANUAL

Human Research Protection Program Policy

UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE INSTITUTIONAL REVIEW BOARD CONFLICTS OF INTEREST

External IRB Review What Does it Mean for Your Institution

KC AWD18: Subaward KC AWD19: Subaward invoicing. September 25, 2013

Obtaining Pre-Study Approvals for Clinical Trials K-30 Module 5 Navigating the Pre-Award Process

Office for Human Subject Protection. University of Rochester

IND Development Process Published on ResearchGo UCLA (

UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE INSTITUTIONAL REVIEW BOARD CONFLICTS OF INTEREST

Partnering with the NIH: Technology Transfer. Why partner?

EIGHT BASIC ELEMENTS OF INFORMED CONSENT

ELEMENTS OF A DATA MONITORING PLAN

COOPERATIVE RESEARCH AND EXTERNAL INVESTIGATORS

Volunteering for Clinical Trials

MARKEY CANCER CENTER STANDARD OPERATING PROCEDURES. SOP No.: MCC Type: Final

Consent Language Does Affect Your Ability to Share

COI IN THE MEDIA 10/8/2012 CONFLICT OF INTEREST IN HUMAN SUBJECT RESEARCH HIGH PROFILE CONFLICT OF INTEREST CASES INVOLVING HUMAN SUBJECTS

ClinicalTrials.gov REGISTRATION REQUIREMENTS

HUMAN RESEARCH PROTECTION PROGRAM PLAN

Expanded Access and the Individual Patient IND

SUBJECT: Public Meeting on Expansion of the Clinical Trial Registry and Results Data Bank [Docket No. NIH ]

1.0 INTRODUCTION AND OVERVIEW

Canadian Cancer Clinical Trials Network Portfolio Eligibility Criteria and Guidelines

NIH Forms E Changes for Human Subject and/or Clinical Trial Applications Attached are the Forms E application pages with the most significant changes

University of California, Irvine Human Research Protections Standard Operating Policies and Procedures

KC AWD18: Subaward KC AWD19: Subaward invoicing. September 25, 2013

Human Subjects Requirements for NIH and AHRQ Applications: Overview of Changes

Protection of Research Participants: The IRB Process and the Winds of Change

NIH Policy on Dissemination of NIH- Funded Clinical Trial Information

HCCA 13 TH ANNUAL COMPLIANCE INSTITUTE LAS VEGAS, NV APRIL 29, 2009

SWOG Subject: Requests for Patient Data Original Release Date: April 2006 Departments Affected: All Revision Date: May 2013

PHS Human Subjects and Clinical Trials Information

VCU Faculty Held IND and IDE Procedure Handbook

Recommendations for Strengthening the Investigator Site Community

Rules of Human Experimentation

ClinicalTrials.gov Registration Guide

What s New in GCP? FDA Draft Guidance Details FIH Multiple Cohort Trials

Investigator Conflict of Interest Disclosure Policy for Human Subjects Research

Defining research compliance Protocol review committees Conflicts of interest Export Controls

Administrative Policies VMC #638.1 and Procedures Manual

SWOG

TITLE: DF/HCC Investigator-Sponsored Multi-Center Research POLICY #: MULTI-100 Page: 1 of 4 Effective Date: 1/31/19

CANCER CENTER SCIENTIFIC REVIEW COMMITTEE

The Role of the IRB in Clinical Trials: What Patients and Families Need to Know. Marjorie A. Speers, Ph.D. Executive Director, WCG Foundation

Trends in Oversight of Human Research Protections?

ROLE OF THE RESEARCH COORDINATOR Investigational New Drug Application-Sponsor Responsibilities 21CFR Part , subpart D

10/9/2012. Alicia Joy, IRB. Wednesday October 10, Please be sure to sign in and take copies of each handout.

Doing Human Subjects Research? Changing NIH Policies May Impact You

Policy Appendix IV: DRCR.net Industry Collaboration Policies Version 5.0, February 2, 2009

UC DAVIS OFFICE OF RESEARCH AAHRPP Preparation UC Davis Human Research Part III Investigator Manual. Cindy Gates IRB Administration

Human Subjects Research Policy Update. Naomi Coll Director of Research Policy and Compliance

April 13, Background

Outline of Discussion

Objectives Discuss the importance of proper data collection. Identify the types of data collected for clinical trials. List potential source documents

Question Yes No. 1. Is the study interventional (a clinical trial)? Study Type data element is Interventional

Policy Appendix IV: DRCR.net Industry Collaboration Policies Version 6.0, August 2, 2017

P41: THE RISKS AND BENEFITS OF HEALTHCARE CONSOLIDATION ON INNOVATION AND CLINICAL RESEARCH IN HEALTH SYSTEMS AND HOSPITALS

Quality Assurance for the Research Team: Connecting Day-to-Day Operations to a Regulatory Framework

Human Feasibility Clinical Trials:

Research: An Essential Component of a Comprehensive MS Center

POST-IRB APPROVAL FDA DRUG (IND) SPONSOR AND INVESTIGATOR RESPONSIBILITY (21 CFR312)

FACTS YOU NEED TO KNOW UNITED STATES OF AMERICA

11.0 FDA-Regulated Research Research Involving Investigational Drugs and Biologics

1201 Maryland Avenue SW, Suite 900, Washington, DC ,

Enterprise Research Risk

Genentech, Inc., its research partners, collaborators, assignees, licensees or designees. Invitation to Participate

METRICS THAT MATTER: ASSESSING WORKFLOW AND STAFFING

Investigator Manual. Human Subjects Protection Program

ClinicalTrials.gov Registration Guide

SELECTED EXCERPTS FROM Intellectual Property Provisions in Clinical Trial Agreements

Translational Medicine From Discovery to Health

All About Awards Kuali Coeus Demo

Radiation - Florida Department of Health Institutional Review Board

USE OF INVESTIGATIONAL DRUGS OR BIOLOGICS IN HUMAN SUBJECTS RESEARCH

11.0 FDA-Regulated Research Research Involving Investigational Drugs and Biologics

3.0 HSC Relation to Other KUMC Committees

Regulatory Documentation and Submissions for C2012 Clinical Trials DCP SOP #1

Compliance Department RESEARCH COMPLIANCE MEMORANDUM

The Revised Common Rule. Ann Johnson, PhD, MPH IRB Director University of Utah

EXPANDED ACCESS: RECENT LEGISLATION AND POLICY UPDATE

Not My Study Challenges of Clinical Trial Disclosure at an Academic Medical Center

Operationalizing Your Study At Grady

FRAMEWORK OF CHARACTERISTICS OF A QUALIFIED SITE TEAM: How Does Yours Measure Up?

Comments from: 1. General comments

INVESTIGATIONAL DRUG MANAGEMENT OVERVIEW

@ALSETF #EAP2015. Jess B. Rabourn CBI Expanded Access Conference July 22, 2015

Florida State University Policy 7-IRB-

Investigational New Drug Development Steps for CRCs

IBM Clinical Trial Management System for Sites

Clinical Trials Office VPR CTO

Transcription:

Financial Administration Development Program: Clinical Research at MSU Kristen Burt, Office of Regulatory Affairs (ORA) Sharon Schooley, Clinical & Translational Sciences Institute (CTSI) February 24, 2017

Why is Clinical Research Important? Key component of translational research Improve health and expand knowledge New discoveries lead to new treatments Important funding mechanism MSU research goals Collaboration between MSU and hospitals 2

MSU External Funding- Sources Source: http://research.msu.edu/wp-content/uploads/2014/12/researchfactsandfigures2016.jpg 3

MSU External Funding- Trends Source: http://research.msu.edu/wp-content/uploads/2014/12/researchfactsandfigures2016.jpg 4

MSU External Funding- Trends Source: http://research.msu.edu/wp-content/uploads/2014/12/researchfactsandfigures2016.jpg 5

Research Project Grant investigators Applicants, awardees, and funding rates NIH Data Book (http://report.nih.gov/ndb/index.aspx) Data provided by the Division of Statistical Analysis and Reporting Branch

NIH Awards Fiscal Year 2016: Research Project Grants to Domestic Institutions of Higher Education Source: https://report.nih.gov/award/index.cfm 7

NIH Awards Fiscal Year 2016: Research Project Grants to Domestic Institutions of Higher Education Source: https://report.nih.gov/award/index.cfm 8

Why is Clinical Research Important to You? 1. Financials- Are different from typical grants because payments may be tied to participants- if you don t enroll participants, you don t get paid 2. Regulatory- Different responsibilities apply depending on the type of project and whose idea it is 3. Metrics- Correct project nature ( activity type in Kuali Coeus) is crucial in reporting on institutional research activity and funding 4. Status/Ranking- Incorrect reporting affects our ranking against other institutions 9

Does any part of your job involve clinical research and/or clinical trials? A. Yes B. No 10

Objectives Understand translational research and apply definitions related to clinical research and clinical trials Recognize how processes differ for clinical research and clinical trials Identify who to contact at MSU with questions 11

What Does it All Mean?? 12

Do you know what translational or clinical research is? A. I don t have a clue B. I might have a vague idea C. I have some knowledge D. I have a fair amount of knowledge E. I would consider myself well-educated in this area 13

Have you participated in a research study before? A. Yes B. No 14

Idea Animals Humans Disseminate Post Dissemination Review Overview of the Translational Research Process See Handout for Detailed Diagram 15

A Translational Research Story: Idea, Animals ( Bench Research): In 1965, Barnett Rosenberg and coworkers at MSU discovered platinumcontaining compounds that inhibited cell division and cured solid tumors resulting from cancer Humans ( Bedside ): The discovery led to Cisplatin, a chemotherapy drug that underwent clinical trial testing for safety and effectiveness Disseminate ( Practice, Policy ): Cisplatin was approved by the FDA in 1978, and was the first platinum compound chemotherapy developed. It is commonly used today in the treatment of many types of cancer MSU developed Carboplatin in 1989, a similar drug which has less side effects. 16

Why Are Definitions Important? Federal regulatory requirements Grants policy requirements Proposal submission- project nature/activity type Facilities & Administrative Costs Contract negotiations Regulatory reviews Institutional metrics 17

Idea Animals Humans Disseminate Post Dissemination Review 18

Basic Research A systematic study directed toward greater knowledge or understanding of the fundamental aspects of phenomena and of observable facts without specific applications towards processes or products in mind... 1 Driven by a scientist's curiosity or interest in a scientific question. The main motivation is to expand man's knowledge, not to create or invent something. 2 1 32 CFR 272.3; 2 Partially taken from Lawrence Berkeley National Laboratory, http://www.lbl.gov/education/elsi/rsearch-main.html 19

Idea Animals Humans Disseminate Post Dissemination Review 20

Research Involving Animals Animal Care Program at MSU Campus Animal Resources Institutional Animal Care and Use Committee Provides regulatory and administrative oversight for animals used in teaching and research endeavors Annually, the MSU community cares for over 50,000 animals from a wide variety of species 21

Idea Animals Humans Disseminate Post Dissemination Review 22

Research Involving Humans Human Research Protection Program at MSU Institutional Review Board Offices Compliance Office Institutional Review Boards The IRB reviews and approves research studies that involve people before the research can start In 2016, there were approximately 1,200 new projects approved, with approximately 20% biomedical 23

Have you completed an application for approval to conduct human research to a MSU Institutional Review A. Yes B. No Board (IRB)? 24

Human Research Clinical Research Clinical Trial Clinical Investigation 25

Human Research Clinical Research Clinical Trial Clinical Investigation 26

Human Subject Living individual about whom an investigator conducting research obtains: data through intervention or interaction or identifiable private information 1 Research Systematic investigation designed to develop or contribute to generalizable knowledge 2 Contact the MSU HRPP 1 45 CFR 46.102(f); 2 45 CFR 46.102(d) 27

Human Research Clinical Research Clinical Trial Clinical Investigation 28

Clinical Research Patient-oriented research: This type of research involves a particular person or group of people or uses materials from humans. Epidemiological and behavioral studies: These types of studies examine the distribution of disease, the factors that affect health, and how people make health-related decisions. Outcomes and health services research: These studies seek to identify the most effective and most efficient interventions, treatments, and services. 1 1https://grants.nih.gov/grants/glossary.htm 29

Human Research Clinical Research Clinical Trial Clinical Investigation 30

Clinical Trial Prospectively assign individuals to one or more interventions to evaluate the effects of those interventions on health-related biomedical or behavioral outcomes. 1 See Handouts for Expanded Definition and Decision Tree Contact the MSU HRPP with questions related to clinicaltrials.gov and training 1https://grants.nih.gov/grants/glossary.htm 31

Clinical Trial Phase 1 and 2 Phase # Subjects Length Purpose % Drugs Successfully Tested 1 20-100 Several months 2 Up to several hundred Several months to 2 years Mainly SAFETY 70 Some shortterm safety, but mainly EFFECTIVENESS 33 32

Clinical Trial Phase 3 and 4 Phase # Subjects 3 Several hundred to several thousand Length Purpose 1-4 years Safety, effectiveness, DOSAGE % Drugs Successfully Tested 25-30 4 Varies Varies Monitor effectiveness, collect ADVERSE EVENTS 33 NA

Human Research Clinical Research Clinical Trial Clinical Investigation 34

Clinical Investigation Any experiment that involves a test article (e.g. drug, device) and one or more human subjects that meets certain requirements per the U.S. Food and Drug Administration (FDA) 1 Requires MSU IRB review and approval and may involve other FDA requirements. Contact the MSU HRPP 121 CFR 56.102 35

Idea Animals Humans Disseminate Post Dissemination Review 36

Disseminate Results distributed (e.g. peer reviewed journals, clinicaltrials.gov, media) Translation to policy and practice New treatments Changes to existing processes New drugs and devices become available for physicians to prescribe New health policies and practices are implemented 37

Another Example: 2003- Michigan Keystone ICU project- 67 hospitals Changing behavior through use of a short safety checklist when inserting catheters into patients Resulted in a significant reduction in bloodstream infections in Michigan Estimated to have saved 1500 lives, $200 million in the first 18 months of the study Leading to new policies and practices for infection control http://www.nejm.org/doi/full/10.1056/nejmoa061115#t=article 38

Idea Animals Humans Disseminate Post Dissemination Review 39

Post Dissemination Review Outcomes research Phase 4 clinical trials After approved for marketing Evaluate the long-term effects for a greater number of patients Monitor effectiveness Monitor adverse events 40

So: We know what type of project it is But Who s idea/protocol is it ( initiator )? MSU researcher? NIH, NSF, NCI, Industry, etc.? Researcher from another institution? 41

MSU Initiated Initiates and conducts an investigation. Agency Initiated Initiates and takes responsibility for the research. Assumes all of the sponsor responsibilities as applicable. MSU has no direct input on or influence over research design. Includes another institution who asks MSU to participate in their investigatorinitiated research. 42

Will you be submitting proposals through Kuali Coeus (KC), formerly the e- Transmittal process? A. Yes B. No 43

Putting it all together: Project Natures (Activity Types in KC) Clinical Research with Human Subjects that is: Agency Initiated or MSU Investigator Initiated Clinical Trial with Human Subjects that is: Agency Initiated or MSU Investigator Initiated Non-Clinical Research with Human Subjects Kuali Coeus incorporates processes to help correctly choose the activity type and initiator Contact CTSI, HRPP (regulatory definitions), or the Office of Sponsored Programs 44

Why Focus on Project Natures/Activity Types? Project natures/activity types drive research metrics Investigator-initiated research activity Funds attributed to clinical research Funds attributed to clinical trials Research activity in general External agency activity Human clinical trials may have additional regulatory requirements 45

An MSU researcher would like to take tissue samples from deceased individuals for research. Does this activity involve human subjects? A. Yes B. No 46

Case Studies 47

Case Study #1 An industry sponsor has contracted with an MSU investigator to collect data from patients already using the sponsor s blood coagulation product as standard of care. Participating in the study will not dictate the course of therapy, other than to be eligible for the study the patient has to already be using the sponsor s product. The purpose of this observational study registry is to get information on routine clinical care for patients with the blood clotting disorder. Is this study a clinical trial? What project nature / activity type is this study? 48

Case Study #2 A study is designed by an MSU researcher to randomly assign individuals to either an experimental intervention to promote weight loss, or to a control intervention. After a year, participants behaviors will be assessed to measure their adherence to exercise regimens. Is this study a clinical trial? What project nature / activity type is this study? 49

Questions? 50

Overview of Clinical Research/Trial Process 51

What and Who are Involved? Other Regulatory Staff (HRPP) Administration (Agreements, Budget & Billing) Principal Investigators The Process Study Staff Sub- Investigators Internal & External Resources 52

Decision to Pursue Confidential Disclosure Agreement Protocol Feasibility Study Completion Closeout Record Retention Study Pre-Award Parallel Processes Budget Preparation Agreements and Negotiation Regulatory Reviews Study Start-Up and Management Financial Contractual Regulatory 53

Decision to Pursue Confidential Disclosure Agreement Protocol Feasibility Study Completion Closeout Record Retention Study Pre-Award Parallel Processes Budget Preparation Agreements and Negotiation Regulatory Reviews Study Start-Up and Management Financial Contractual Regulatory 54

Confidential Disclosure Agreement (CDA) Legal contract that governs the exchange of proprietary or confidential information, used to: share proprietary information with an external party for a limited purpose while protecting it from being disclosed to others or the public. avoid forfeiture of patent rights due to premature public disclosure. Can only be signed by MSU Technologies CDA: Contact MSU Technologies with questions. Feasibility: Contact CTSI with questions. 55

Feasibility An assessment of a project s needs including: Study subject base/recruitment plans Project logistics and available resources Financial obligations Clinical Research is a BUSINESS, requires a strategic plan Business tools can be used for this process Operational budgets, templates, break-even analysis CTSI is available to help 56

Decision to Pursue Confidential Disclosure Agreement Protocol Feasibility Study Completion Closeout Record Retention Study Pre-Award Parallel Processes Budget Preparation Agreements and Negotiation Regulatory Reviews Study Start-Up and Management Financial Contractual Regulatory 57

Parallel Processes and Regulatory Reviews Department / College Work-Up, Submission: Coverage Analysis (if required) Contract Review by Appropriate Office Submit IRB Application Additional Required Reviews? Obtain All Needed Institutional Reviews &/or Approvals, CGA Account Setup, & Notify All Parties Coverage Analysis: Contact HRPP Compliance Contract Review: Contact Business Connect or Office of Sponsored Programs IRB: Contact HRPP Additional Reviews: Contact appropriate offices 58

Budget Preparation Analyze protocol and study documents to determine costs and required study services Create overall study budget including all study costs, e.g. upfront/start up, per-subject, variable, and federal vs industry budgeting parameters Negotiate when possible, e.g. industrial sponsor budgets are generalized across sites Budget Preparation, negotiation: Contact CTSI 59

Agreements and Negotiations Liability, publication, intellectual property, subject injury, etc. Includes subcontracts with external service providers Work with the appropriate MSU office (Business Connect, Office of Sponsored Programs) Agreements and negotiations: Contact Business Connect or Office of Sponsored Programs 60

Research Award Transactions by Fiscal Year 2500 2000 2233 2005 2167 2024 2040 1500 1000 500 0 266 267 262 220 241 2012 2013 2014 2015 2016 Research Awards Clinical Research/Trial Awards 61

Research Award Transactions by Fiscal Year: Clinical Research/Trial 300 250 200 150 100 50 0 90 176 123 119 70 69 144 143 150 172 2012 2013 2014 2015 2016 Clinical Trial Clinical Research 62

NIH Proposals by Fiscal Year 500 400 300 200 100 0 385 361 292 283 291 20 24 25 47 36 2012 2013 2014 2015 2016 Total Proposals Clinical Research/Trial Proposals 63

NIH Award Transactions by Fiscal Year 250 200 150 197 153 205 193 150 100 50 0 8 10 22 14 13 2012 2013 2014 2015 2016 Total Awards Clinical Research/Trials Awards 64

NIH Award Transactions by Fiscal Year: Clinical Research/Trial Awards 25 20 15 10 5 0 17 8 9 4 8 4 2 5 6 4 2012 2013 2014 2015 2016 Clinical Trial Clinical Research 65

Decision to Pursue Confidential Disclosure Agreement Protocol Feasibility Study Completion Closeout Record Retention Study Pre-Award Parallel Processes Budget Preparation Agreements and Negotiation Regulatory Reviews Study Start-Up and Management Financial Contractual Regulatory 66

Financial Invoice sponsor per contract/grant Track sponsor payments; review for accuracy Allocate payments based on initial cost projections Pay service providers per billing grid, subcontract, service quotes Study subject stipends and 1099 Effort tracking, labor distributions, & effort reports 67

Contractual Be familiar with the executed contract Contract amendments, budget revisions Reporting per contract/grant requirements Track study subject entry, visits, and study event completion Management of study drugs, devices, equipment 68

Regulatory Compliance Affects Our Reputation Assure all necessary approvals are in place Follow the IRB approved protocol Follow regulatory submission requirements For FDA projects: Be familiar with regulations and long term impacts The FDA relies on data that sponsors submit to decide whether a drug should be approved 69

Decision to Pursue Confidential Disclosure Agreement Protocol Feasibility Study Completion Closeout Record Retention Study Pre-Award Parallel Processes Budget Preparation Agreements and Negotiation Regulatory Reviews Study Start-Up and Management Financial Contractual Regulatory 70

Study Closeout and Record Retention Any remaining contractual obligations Regulatory submission requirements Record retention requirements (e.g. contract, regulation), it can be many years (e.g. 25) Reporting per contract/grant requirements Final invoicing, payment allocations Study closeout of finances 71

Account Closeouts: Count 2500 2000 1500 1000 500 0 2,005 1,361 1,381 1,073 811 554 2011 2012 2013 2014 2015 2016 Count Pending Closeouts as of 2/17/2017: 415

Account Closeouts: Average Number of Days to Closeout 100 80 60 40 20 0 80.7 77.1 69.4 40.4 46.6 32.3 2011 2012 2013 2014 2015 2016 Average Number of Days to Closeout Pending Closeouts as of 2/17/2017: 415

REVIEW: Best Practices Contact appropriate office with questions they are here to help! Project feasibility - is the study realistic to do? Correctly assign project natures/activity types - METRICS! F & A rates! Budgeting - assess ALL project-related costs, negotiate if applicable 74

REVIEW: Best Practices Complete parallel submission processescontract/grant, IRB, budget processes (i.e. coverage analysis) Have appropriate University offices sign contracts and agreements Proactive post-award management Maintain regulatory compliance 75

Does any part of your job involve clinical research and/or clinical trials? A. Yes B. No 76

Questions? 77

Vice President for Research & Graduate Studies Clinical & Translational Sciences Institute (CTSI) Biomedical Research Informatics Core (BRIC) Develop New Opportunities With Research Partners Office of Clinical Research (OCR) Research Collaboration Data oversight throughout study lifecycle Biologic Sample Collection & Processing Research Process Navigation Project Feasibility / Needs Assessment 78 Data Mgt. & Informatics, Access to Software Tools Data Security & Data Storage Subject Recruitment & Retention Strategies Access to Clinical Research Personnel & Facilities Pre & Post Award Financial Training & Support

For additional questions, please contact us Kristen Burt- ORA burtkris@ora.msu.edu Sharon Schooley- CTSI sharon.schooley@hc.msu.edu 79